ICYMI, this week we had stories about skin cancer, FDA approvals, vitiligo, consumer trends, and more.
Click to see a preview of what to expect this week.
Susan Taylor, MD, FAAD, provides an overview of sun-caused skin damage.
Susan Taylor, MD, FAAD, compares how skin damage can occur in individuals with skin of color compared with individuals with light skin.
An expert offers considerations and developmentally appropriate interventions to promote high-quality, patient-centered pediatric infusion care.
Click here to answer this week's poll.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
This week's edition of the Mainstream Patient features stories about night creams, skincare routines, beauty sales, and more.
Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.
In this week’s Pointers with Dr Portela, the 208SkinDoc talks about how to overcome hormonal acne and other skin care tips.
Drs. Neal Bhatia and Angela Lamb provide an overview of atopic dermatitis and its prevalence in patients with skin of color (SOC).
Dermatology experts discuss strategies to increase awareness of advances in AD in patients with SOC.
MW005 treatment for low-risk basal cell carcinoma would offer patients an alternative to surgical excision.
Technology and care navigators are key to managing this growing population
Results published in the Journal of the American Medical Association (JAMA) Dermatology detailed the efficacy and safety of berdazimer gel 10.3%, in the treatment of molluscum contagiosum.
Pearl Grimes, MD, FAAD, and director of the Grimes Center of Medical and Aesthetic Dermatology and the Vitiligo & Pigmentation Institute of Southern California in Los Angeles, explains why the FDA approval of ruxolitinib cream 1.5% is monumental in the treatment of vitiligo.
Studies show that patients with atopic dermatitis may benefit from a multidisciplinary approach.
The American Academy of Dermatology Association shares its recommendations for anti-aging products and reducing skin aging.